Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAM2029
CAM2029
FDA declines to approve Camurus' rare hormone disorder drug
Reuters
Tue, 10/22/24 - 11:24 am
Camurus
FDA
CAM2029
acromegaly
Novartis picks up its development option in $700M rare-disease pact
Fierce Biotech
Tue, 09/10/13 - 11:27 am
Novartis
Camarus
CAM2029
acromegaly